| 0 (0%) | 07-26 19:29 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 16.38 | 1-year : | 19.14 |
| Resists | First : | 14.02 | Second : | 16.38 |
| Pivot price | 12.98  |
|||
| Supports | First : | 11.89 | Second : | 10.56 |
| MAs | MA(5) : | 13.46  |
MA(20) : | 12.58 |
| MA(100) : | 8.81 |
MA(250) : | 6.03 |
|
| MACD | MACD : | 0.7 |
Signal : | 0.8 |
| %K %D | K(14,3) : | 73.3 |
D(3) : | 81.5 |
| RSI | RSI(14): 63.8 |
|||
| 52-week | High : | 14.02 | Low : | 3.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ ADMA ] has closed below upper band by 43.7%. Bollinger Bands are 55.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 13.36 - 13.42 | 13.42 - 13.49 |
| Low: | 12.79 - 12.85 | 12.85 - 12.92 |
| Close: | 13.05 - 13.16 | 13.16 - 13.27 |
Fri, 26 Jul 2024
ADMA Biologics Taps Brad Tade as CFO - MarketWatch
Fri, 26 Jul 2024
ADMA Biologics Appoints Brad Tade as New CFO and Treasurer - TipRanks
Fri, 26 Jul 2024
(ADMA) Trading Advice - Stock Traders Daily
Fri, 26 Jul 2024
ProShare Advisors LLC Has $358,000 Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Thu, 25 Jul 2024
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why - Yahoo Finance
Thu, 25 Jul 2024
Sei Investments Co. Has $2.60 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 232 (M) |
| Shares Float | 228 (M) |
| Held by Insiders | 2.5 (%) |
| Held by Institutions | 78.3 (%) |
| Shares Short | 7,270 (K) |
| Shares Short P.Month | 9,210 (K) |
| EPS | -0.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.66 |
| Profit Margin | -1.3 % |
| Operating Margin | 26.6 % |
| Return on Assets (ttm) | 8.5 % |
| Return on Equity (ttm) | -2.5 % |
| Qtrly Rev. Growth | 43.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.22 |
| EBITDA (p.s.) | 0.23 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 21 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -658 |
| PEG Ratio | 0 |
| Price to Book value | 19.93 |
| Price to Sales | 10.77 |
| Price to Cash Flow | 143.22 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|